S&P 500   4,569.78
DOW   36,204.44
QQQ   386.32
Are penny stocks worth it? Should you invest in penny stocks?
All the trading advice you’ve ever received boils down to this (Ad)
Why do tech stocks go down when interest rates rise?
Own Dollar General? Hurry and take this advice before earnings
New CBOE “special perk” helps traders target income every weekend (Ad)
Pure Storage stock fumbles for a rare buying opportunity
Black Swan: this small cap surged over 1000% last week
New CBOE “special perk” helps traders target income every weekend (Ad)
2 energy drink makers to wake up your portfolio
Snowflake’s bullish tailwind is turning into a gale-force wind
S&P 500   4,569.78
DOW   36,204.44
QQQ   386.32
Are penny stocks worth it? Should you invest in penny stocks?
All the trading advice you’ve ever received boils down to this (Ad)
Why do tech stocks go down when interest rates rise?
Own Dollar General? Hurry and take this advice before earnings
New CBOE “special perk” helps traders target income every weekend (Ad)
Pure Storage stock fumbles for a rare buying opportunity
Black Swan: this small cap surged over 1000% last week
New CBOE “special perk” helps traders target income every weekend (Ad)
2 energy drink makers to wake up your portfolio
Snowflake’s bullish tailwind is turning into a gale-force wind
S&P 500   4,569.78
DOW   36,204.44
QQQ   386.32
Are penny stocks worth it? Should you invest in penny stocks?
All the trading advice you’ve ever received boils down to this (Ad)
Why do tech stocks go down when interest rates rise?
Own Dollar General? Hurry and take this advice before earnings
New CBOE “special perk” helps traders target income every weekend (Ad)
Pure Storage stock fumbles for a rare buying opportunity
Black Swan: this small cap surged over 1000% last week
New CBOE “special perk” helps traders target income every weekend (Ad)
2 energy drink makers to wake up your portfolio
Snowflake’s bullish tailwind is turning into a gale-force wind
S&P 500   4,569.78
DOW   36,204.44
QQQ   386.32
Are penny stocks worth it? Should you invest in penny stocks?
All the trading advice you’ve ever received boils down to this (Ad)
Why do tech stocks go down when interest rates rise?
Own Dollar General? Hurry and take this advice before earnings
New CBOE “special perk” helps traders target income every weekend (Ad)
Pure Storage stock fumbles for a rare buying opportunity
Black Swan: this small cap surged over 1000% last week
New CBOE “special perk” helps traders target income every weekend (Ad)
2 energy drink makers to wake up your portfolio
Snowflake’s bullish tailwind is turning into a gale-force wind

Avinger Stock Price, News & Analysis (NASDAQ:AVGR)

$3.38
+0.47 (+16.15%)
(As of 12/4/2023 ET)
Compare
Today's Range
$2.90
$3.49
50-Day Range
$2.85
$7.61
52-Week Range
$2.78
$24.30
Volume
117,770 shs
Average Volume
541,425 shs
Market Capitalization
$4.63 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$5.00

Avinger MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
47.9% Upside
$5.00 Price Target
Short Interest
Healthy
0.37% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.85mentions of Avinger in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($3.59) to ($2.26) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.36 out of 5 stars


AVGR stock logo

About Avinger Stock (NASDAQ:AVGR)

Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) in the United States and internationally. It develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures. The company's lumivascular products comprise Lightbox imaging consoles, as well as the Ocelot family of catheters, including Ocelot and Tigereye, which are designed to allow physicians to penetrate a total blockage in an artery; and Pantheris, an image-guided atherectomy device that allows physicians to precisely remove arterial plaque in PAD patients. In addition, its chronic total occlusion (CTO)-crossing catheters, Wildcat and Kittycat 2, which employs a proprietary design that uses a rotational spinning technique allowing the physician to switch between passive and active modes when navigating across a CTO. Further, the company develops IMAGE-BTK for the treatment of PAD lesions below-the-knee. It markets and sells its products to interventional cardiologists, vascular surgeons, and interventional radiologists. The company was incorporated in 2007 and is headquartered in Redwood City, California.

AVGR Stock Price History

AVGR Stock News Headlines

Trading Experts Call It “The Perfect Tesla Trade”
Thanks to a new discovery linked to shares of Tesla, regular folks can now target gains of 100% or more in six days or less. New research shows it’s happened 23 different times this year. The next trade is scheduled for this Thursday.
Avinger, Inc.: Avinger Reports Third Quarter 2023 Results
Avinger Reports Third Quarter 2023 Results
Avinger (AVGR) Reports Q3 Loss, Lags Revenue Estimates
Avinger Earnings Preview
Trading Experts Call It “The Perfect Tesla Trade”
Thanks to a new discovery linked to shares of Tesla, regular folks can now target gains of 100% or more in six days or less. New research shows it’s happened 23 different times this year. The next trade is scheduled for this Thursday.
Avinger Raises $5.3 Million via At-The-Market Facility
What's Going On With Avinger Inc. Stock Today?
Avinger jumps 28%, enters ATM equity offering
Avinger Stock Is Soaring Again: What's Going On?
Avinger Inc
Avinger (AVGR) Receives a Buy from H.C. Wainwright
Avinger Reports Second Quarter 2023 Results
See More Headlines
Receive AVGR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Avinger and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
10/26/2023
Today
12/04/2023
Fiscal Year End
12/31/2023
Next Earnings (Estimated)
3/20/2024

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:AVGR
Employees
71
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$5.00
High Stock Price Target
$5.00
Low Stock Price Target
$5.00
Potential Upside/Downside
+47.9%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$-17,620,000.00
Net Margins
-225.61%
Pretax Margin
-225.61%

Debt

Sales & Book Value

Annual Sales
$8.27 million
Book Value
$8.36 per share

Miscellaneous

Free Float
1,311,000
Market Cap
$4.63 million
Optionable
Not Optionable
Beta
1.30
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Key Executives

  • Mr. Jeffrey M. Soinski (Age 61)
    President, CEO & Director
    Comp: $605.15k
  • Mr. Nabeel P. Subainati (Age 39)
    VP of Finance, Principal Financial Officer & Accounting Officer
    Comp: $295.85k
  • Mr. Himanshu N. Patel (Age 63)
    Chief Technology Officer
    Comp: $423.09k
  • Mr. Keith Schaefer
    Chief Operating Officer














AVGR Stock Analysis - Frequently Asked Questions

Should I buy or sell Avinger stock right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Avinger in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" AVGR shares.
View AVGR analyst ratings
or view top-rated stocks.

What is Avinger's stock price target for 2024?

1 brokers have issued twelve-month price objectives for Avinger's stock. Their AVGR share price targets range from $5.00 to $5.00. On average, they expect the company's stock price to reach $5.00 in the next twelve months. This suggests a possible upside of 47.9% from the stock's current price.
View analysts price targets for AVGR
or view top-rated stocks among Wall Street analysts.

How have AVGR shares performed in 2023?

Avinger's stock was trading at $16.2750 at the beginning of 2023. Since then, AVGR stock has decreased by 79.2% and is now trading at $3.38.
View the best growth stocks for 2023 here
.

Are investors shorting Avinger?

Avinger saw a decline in short interest during the month of November. As of November 15th, there was short interest totaling 4,500 shares, a decline of 70.4% from the October 31st total of 15,200 shares. Based on an average trading volume of 1,910,000 shares, the days-to-cover ratio is currently 0.0 days. Approximately 0.4% of the shares of the company are short sold.
View Avinger's Short Interest
.

When is Avinger's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, March 20th 2024.
View our AVGR earnings forecast
.

How were Avinger's earnings last quarter?

Avinger, Inc. (NASDAQ:AVGR) issued its quarterly earnings data on Thursday, October, 26th. The medical device company reported ($2.92) earnings per share for the quarter, missing analysts' consensus estimates of ($2.85) by $0.07. The medical device company earned $1.82 million during the quarter, compared to the consensus estimate of $2.40 million. Avinger had a negative trailing twelve-month return on equity of 6,767.92% and a negative net margin of 225.61%.

When did Avinger's stock split?

Shares of Avinger reverse split on the morning of Wednesday, September 13th 2023. The 1-15 reverse split was announced on Wednesday, September 13th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, September 13th 2023. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.

What other stocks do shareholders of Avinger own?
When did Avinger IPO?

(AVGR) raised $60 million in an initial public offering (IPO) on Friday, January 30th 2015. The company issued 4,600,000 shares at $12.00-$14.00 per share. Canaccord Genuity and Cowen and Company served as the underwriters for the IPO and Oppenheimer, BTIG and Stephens were co-managers.

How do I buy shares of Avinger?

Shares of AVGR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NASDAQ:AVGR) was last updated on 12/5/2023 by MarketBeat.com Staff

My Account -